- $499.19m
- $470.91m
- $320.17m
Brief: AngioDynamics Reports Q4'23 Financial Results
Brief: AngioDynamics Q4 Adjusted EPS USD 0.02 Vs. Estimate USD 0.02
AngioDynamics Inc expected to post earnings of 2 cents a share - Earnings Preview
Brief: AngioDynamics To Sell Dialysis Product Portfolio, Biosentry Product For $100 Mln
Brief: Angiodynamics Inc Provides Updates On Action Brought By C.R. Bard Inc And Bard Peripheral Vascular Inc In US District Court
U.S. STOCKS ON THE MOVE-Piedmont Lithium, Walmart, Kilroy Realty
U.S. STOCKS ON THE MOVE-Walmart, JD.Com, Crinetics
AngioDynamics Inc falls on lower 2023 results outlook
AngioDynamics Inc reports results for the quarter ended in February - Earnings Summary
U.S. STOCKS ON THE MOVE-Neogen Corp, Freight Technologies, Philip Morris
AngioDynamics tumbles after lower 2023 results guidance
Brief: Angiodynamics Reports Fiscal 2023 Q3 Financial Results
Brief: AngioDynamics Cuts Fiscal Year 2023 Guidance
AngioDynamics Inc expected to post a loss of 1 cent a share - Earnings Preview
AngioDynamics Inc reports results for the quarter ended in November - Earnings Summary
Brief: AngioDynamics Reports Fiscal 2023 Second Quarter Financial Results
AngioDynamics Inc expected to post a loss of 1 cent a share - Earnings Preview
Brief: Jury Enters Verdict That Certain Of Angiodynamics Inc's Implantable Port Products Infringe Certain U.S. Patents Held By BARD
AngioDynamics falls as jury finds it violated Becton Dickinson patents